INTRODUCTION

4
To determine whether the number of E. coli colonies tested per plate would significantly 1 0 0 impact on the measured diversity of enteric E. coli, groups of 5, 10, 15 or 20 E. coli single 1 0 1 colonies were selected from individual samples that had been cultured on Brilliance agar. 1 0 2
Samples were from randomly selected hospitalised patients with E. coli bacteraemia 1 0 3 receiving antibiotics (n=5), and from randomly selected hospitalised patients who did not 1 0 4
have bacteraemia and were not receiving antibiotics at the time (n=5). Individual colonies 1 0 5
were boiled at 90 °C for 10 min to lyse the cells and release DNA; these were then subject to 1 0 6
Randomly-Amplified-Polymorphic-DNA (RAPD)-PCR using primers and methods previously 1 0 7
reported [17] (Table S1 ). receiving antimicrobial treatment, while five patients were non-bacteraemic in-patients and 1 2 9 had not been receiving any antibiotics for 30 days prior to sample collection.
Overall, a median of two RAPD patterns was identified per sample; however E. coli 1 3 1 bacteraemia patients had a reduced range of RAPD types (median one, range 1-3) 1 3 2 compared with non-antibiotic exposed patients (median two, range 1-4). Examination of 15 1 3 3 colonies allowed detection of increased diversity in just one sample tested in each group 1 3 4 compared with examination of 10 colonies. Further expansion to examine 20 colonies did not 1 3 5
increase the observed diversity of E. coli per sample in either group. Overall there was no 1 3 6 difference in the number of potential different genotypes detectable by RAPD-PCR when 1 3 7 selecting 10 or 20 colonies (P >0.05) ( Figure 1 and Table S2 ). As such, for subsequent 1 3 8
work, a practical approach of selecting 10 colonies per patient was adopted. 1 3 9
Assessment of E. coli diversity between patient groups 1 4 0 E. coli diversity was then compared between larger sets of enteric samples from E. (range 1-5) although the differences between the three groups overall was not significant 1 5 3 (p=0.06) (Figure 2 ).
5 4
We considered whether the type of sample affected our results and so compared data 1 5 5
obtained from rectal swabs and faecal samples; rectal swabs were performed largely for the 1 5 6 purpose of screening for carriage of carbapenem-resistant organisms (CRO) using risk-1 5 7
based algorithms and could represent a marker of prior healthcare exposure. Importantly, 1 5 8 however, there was no significant difference between the two types of sample ( Figure S2 ).
Rectal swabs may be obtained earlier during each hospital admission than stool samples, 1 6 0 reducing the effect of recent antibiotic exposure on the diversity detected. The value of using 1 6 1 rectal swabs is a useful observation, since inpatients are often unable to provide a faecal 1 6 2 sample, while rectal swabs are increasingly obtained as part of routine screening practice.
6 3
Overall, we found a narrower diversity of E. coli in E. coli bacteraemia patients compared to 1 6 4 control hospitalised patients. Although our study was not sufficiently powered to directly 1 6 5 compare the E. coli bacteraemia group with the 'other Gram negative bacteraemia' group, 1 6 6 our data suggest that the reduced diversity of E. coli in the enteric microbiota of E. coli 1 6 7 bacteraemia patients may be specific to this group, and not necessarily related to concurrent 1 6 8 antimicrobial exposure. We speculate that pathogenic E. coli strains causing bacteraemia 1 6 9 may outcompete and dominate the gut microbiota. Whether this is related to past 1 7 0 antimicrobial consumption or other pressures affecting the enteric reservoir of in-patients will 1 7 1 require further study using specifically selected populations of patients with known 1 7 2 antimicrobial history.
Our study had limitations, in that enteric samples were only available from around a quarter 1 7 5 of eligible patients with bacteraemia, and, for practical reasons, efforts to culture E. coli from 1 7 6
all patients did not include heat shock or novobiocin-enrichment which, in separate studies, 1 7 7
we found did improve yield (not shown). However, the number of samples evaluated was 1 7 8 high, and there is no evidence to suggest these limitations would have affected any one 1 7 9
patient group more than another. Frequency of different numbers of RAPD patterns among E. coli bacteraemia patients (n=74), patients with other Gram negative bacteraemia (n=42), and non-antibiotic exposed inpatient controls who had no infection and were not taking antibiotics (n=70). Although a difference was detected between the two main groups (E. coli bacteraemia and nonantibiotic inpatient controls, p=0.029), there were no overall differences between the three groups (p=0.06).
